CIOTechOutlook >> Magazine >> November - 2015 issue

CromDx: Mutating the Study of Genomics and Research to New Heights

By

A historical moment was christened in the year 1953, when James Watson and Francis crick discovered the double helical structure of the DNA. It was a path breaking development in the history of mankind that can also be considered as the first step in the study of Genomics. A voluminous research work in the life science is undertaken by scientists and virologist with the assistance of companies that provide technological and other assistance. Laying the ground work for the research and development in advance clinical care requirements, assisted by an expertise that has covered many geographical miles, is the India based Cromdx, having office in New York, USA, the company is promising to provide solutions for easy and precise diagnostics along with cure for various diseases, through ingenious and advance research methodologies.

To achieve this feat, they are integrating the traditional pathology with molecular biology with the assistance of a professional team, who employ their thought process through practical expertise, to find effective solutions. Further to employing their own research force, the help of experts from other institutions like AIIMS, MAMC, and CDRI are also sought, in order to get effective remedies. To work in its line the company has state of the art molecular diagnostic lab such as the RT-PCR, Next Gen Sequencing, Sangersequencing, and Molecular sequencing, which do not only help doctors in judging a patient’s health condition, but helps minimize the procedures involved in clinical diagnosis and also assists a patient to choose the treatment befitting his or her medical condition, based on the results. In addition, it also makes it easier for the doctors to know about the patient’s medical history and prescribe the correct medicine without having to experiment with prescription of drugs. They do it by providing wide range of bio technology services such as Biomarker discovery, integration and Co-relations studies, literature mining, and custom bio informatics in the departments of Cardiology, Oncology, Neurology, Nephrology and Wellness not only in India but to many international destinations such as Middle East, Nigeria, Mauritius and Sri Lanka.

Making Inroads for the Future
Even though the world of medical science is au fait with all the latest equipments, yet there are times, when unknown viruses make inroads in the human cells and spread deadly diseases causing great loss to humanity. The company is preparing itself for such impending challenges by encouraging its workforce to come out with the best possible diagnosis mechanisms by conducting robust and extensive research on various domains such as Genomics and Molecular studies.

On The Deck

CXO Insights

Open Standards as the Next Frontier in...

By Manjunath Bhat, Director R&D, AirWatch by VMware

Put Your Storage to Work with Data Virtualization

By Graham Smith, Director-Virtualization Products, Primary Data

GST will open the door to cloud adoption in the...

By William Rau, Senior director, engineering, Avalara

Facebook